Literature DB >> 24705054

Weak C-H···X (X = O, N) hydrogen bonds in the crystal structure of dihydroberberine.

Subramanya Pingali1, James P Donahue2, Florastina Payton-Stewart1.   

Abstract

Dihydroberberine (systematic name: 9,10-dimethoxy-6,8-dihydro-5H-1,3-dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline), C20H19NO4, a reduced form of pharmacologically important berberine, crystallizes from ethanol without interstitial solvent. The molecule shows a dihedral angle of 27.94 (5)° between the two arene rings at the ends of the molecule, owing to the partial saturation of the inner quinolizine ring system. Although lacking classical O-H or N-H donors, the packing in the crystalline state is clearly governed by C-H···N and C-H···O hydrogen bonds involving the two acetal-type C-H bonds of the 1,3-dioxole ring. Each dihydroberberine molecule is engaged in four hydrogen bonds with neighbouring molecules, twice as donor and twice as acceptor, thus forming a two-dimensional sheet network that lies parallel to the (100) plane.

Entities:  

Keywords:  berberine derivative; biological activity; crystal structure; dihydroberberine; hydrogen bonding

Mesh:

Substances:

Year:  2014        PMID: 24705054      PMCID: PMC4165590          DOI: 10.1107/S2053229614003751

Source DB:  PubMed          Journal:  Acta Crystallogr C Struct Chem        ISSN: 2053-2296            Impact factor:   1.172


  24 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli.

Authors:  D Sun; S N Abraham; E H Beachey
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

3.  Berberine sulfate: antimicrobial activity, bioassay, and mode of action.

Authors:  A H Amin; T V Subbaiah; K M Abbasi
Journal:  Can J Microbiol       Date:  1969-09       Impact factor: 2.419

4.  Possible mechanism of antidiarrhoeal effect of berberine.

Authors:  M H Akhter; M Sabir; N K Bhide
Journal:  Indian J Med Res       Date:  1979-08       Impact factor: 2.375

5.  Improved delivery through biological membranes XVI. Enhancement of the brain-specificity of a dihydropyridine formed from pyridinium salt drug delivery system by controlled infusion.

Authors:  M Brewster; N Bodor
Journal:  J Parenter Sci Technol       Date:  1983 Sep-Oct

6.  Palmatine and berberine isolation artifacts.

Authors:  Radek Marek; Pavlína Seckárová; Dagmar Hulová; Jaromír Marek; Jirí Dostál; Vladimír Sklenár
Journal:  J Nat Prod       Date:  2003-04       Impact factor: 4.050

7.  Process-induced phase transformation of berberine chloride hydrates.

Authors:  Henry H Y Tong; Aviva S F Chow; H M Chan; Albert H L Chow; Yetta K Y Wan; Ian D Williams; Fanny L Y Shek; Chak K Chan
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

8.  Protoberberine alkaloids as antimalarials.

Authors:  J L Vennerstrom; D L Klayman
Journal:  J Med Chem       Date:  1988-06       Impact factor: 7.446

9.  Fluconazole assists berberine to kill fluconazole-resistant Candida albicans.

Authors:  De-Dong Li; Yi Xu; Da-Zhi Zhang; Hua Quan; Eleftherios Mylonakis; Dan-Dan Hu; Ming-Bang Li; Lan-Xue Zhao; Liang-Hua Zhu; Yan Wang; Yuan-Ying Jiang
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

10.  Synthesis and cytotoxicity evaluation of 13-n-alkyl berberine and palmatine analogues as anticancer agents.

Authors:  Lei Zhang; Jingjing Li; Fei Ma; Shining Yao; Naisan Li; Jing Wang; Yongbin Wang; Xiuzhen Wang; Qizheng Yao
Journal:  Molecules       Date:  2012-09-25       Impact factor: 4.411

View more
  3 in total

1.  Tetrahydroberberine, a pharmacologically active naturally occurring alkaloid.

Authors:  Subramanya Pingali; James P Donahue; Florastina Payton-Stewart
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-03-10       Impact factor: 1.172

2.  Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity.

Authors:  Doaa A Ghareeb; Samar R Saleh; Mohamed G Seadawy; Mohammed S Nofal; Shaymaa A Abdulmalek; Salma F Hassan; Shaimaa M Khedr; Miral G AbdElwahab; Ahmed A Sobhy; Ali Saber Ali Abdel-Hamid; Abdelrahman Mohamed Yassin; Alshimaa A Abd Elmoneam; Aliaa A Masoud; Mohamed M Y Kaddah; Sally A El-Zahaby; Abdulaziz Mohsen Al-Mahallawi; Alaa M El-Gharbawy; Ahmed Zaki; Inas K Seif; Marwa Y Kenawy; Magdy Amin; Khaled Amer; Maha Adel El Demellawy
Journal:  J Pharm Investig       Date:  2021-09-06

3.  Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.

Authors:  Beth Buchanan; Qingfang Meng; Mathieu-Marc Poulin; Jonathan Zuccolo; Chike Godwin Azike; Joseph Gabriele; David Charles Baranowski
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.